Gault Cheryl sold RAPP
September 8, 2025 · Form 4 insider transaction
Gault Cheryl sold 5,000 shares of Rapport Therapeutics, Inc. at $38.33 per share, a transaction worth $191.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,000
Price
$38.33
Total value
$191.7K
InsiderGault Cheryl
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 8, 2025
Filing dateSeptember 10, 2025
Shares owned after171,928
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024.